IL140335A0 - Transdermal patch for the release of estradiol - Google Patents

Transdermal patch for the release of estradiol

Info

Publication number
IL140335A0
IL140335A0 IL14033599A IL14033599A IL140335A0 IL 140335 A0 IL140335 A0 IL 140335A0 IL 14033599 A IL14033599 A IL 14033599A IL 14033599 A IL14033599 A IL 14033599A IL 140335 A0 IL140335 A0 IL 140335A0
Authority
IL
Israel
Prior art keywords
estradiol
matrix
release
transdermal patch
present
Prior art date
Application number
IL14033599A
Other languages
English (en)
Original Assignee
Rottapharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rottapharm Bv filed Critical Rottapharm Bv
Publication of IL140335A0 publication Critical patent/IL140335A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IL14033599A 1998-06-22 1999-06-22 Transdermal patch for the release of estradiol IL140335A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19827732A DE19827732A1 (de) 1998-06-22 1998-06-22 Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
PCT/EP1999/004305 WO1999066908A1 (en) 1998-06-22 1999-06-22 Matrix-type transdermal patch for steroid hormones

Publications (1)

Publication Number Publication Date
IL140335A0 true IL140335A0 (en) 2002-02-10

Family

ID=7871628

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14033599A IL140335A0 (en) 1998-06-22 1999-06-22 Transdermal patch for the release of estradiol

Country Status (17)

Country Link
US (1) US6440454B1 (de)
EP (1) EP1089722B1 (de)
JP (1) JP2002518434A (de)
KR (1) KR20010053072A (de)
CN (1) CN1306421A (de)
AT (1) ATE217793T1 (de)
AU (1) AU4775499A (de)
BR (1) BR9911411A (de)
CA (1) CA2333586A1 (de)
DE (2) DE19827732A1 (de)
DK (1) DK1089722T3 (de)
ES (1) ES2177295T3 (de)
HU (1) HUP0102785A2 (de)
IL (1) IL140335A0 (de)
PL (1) PL345061A1 (de)
PT (1) PT1089722E (de)
WO (1) WO1999066908A1 (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1280485A4 (de) * 2000-02-29 2006-11-29 Zars Inc Verbessertes transdermales medizinpflaster
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
WO2002011768A1 (en) 2000-08-03 2002-02-14 Antares Pharma Ipl Ag Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
WO2005039531A1 (en) * 2003-10-10 2005-05-06 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
US20040062794A1 (en) * 2002-09-30 2004-04-01 Lee Shulman 17Beta- estradiol/levonorgestrel transdermal patch for hormone replacement therapy
US20040086551A1 (en) * 2002-10-30 2004-05-06 Miller Kenneth J. Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
MEP14008A (en) 2003-02-21 2010-06-10 Bayer Schering Pharma Ag Uv stable transdermal therapeutic plaster
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
GB0409498D0 (en) * 2004-04-28 2004-06-02 Hunter Fleming Ltd Transdermal steroid formulation
US7425340B2 (en) 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
WO2007035942A2 (en) * 2005-09-23 2007-03-29 Alza Corporation Transdermal risperidone delivery system
EP1928924B1 (de) * 2005-09-23 2011-05-18 National Starch and Chemical Investment Holding Corporation Klebstoffe auf acrylpolymerbasis
NZ571460A (en) 2006-04-21 2010-10-29 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
WO2008067991A2 (en) * 2006-12-08 2008-06-12 Antares Pharma Ipl Ag Skin-friendly drug complexes for transdermal administration
US20080152592A1 (en) * 2006-12-21 2008-06-26 Bayer Healthcare Llc Method of therapeutic drug monitoring
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
WO2008115224A2 (en) * 2007-03-20 2008-09-25 Bayer Healthcare Llc Method of analyzing an analyte
JP2012504609A (ja) * 2008-10-06 2012-02-23 マイラン・テクノロジーズ，インコーポレイテッド アモルファスロチゴチン経皮システム
PT2613772T (pt) 2010-09-06 2017-03-06 Bayer Ip Gmbh Emplastros transdérmicos de dose baixa com alta libertação de fármaco
AU2015203180B2 (en) * 2010-09-06 2016-06-30 Bayer Intellectual Property Gmbh Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner)
DE102010040299A1 (de) * 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
RS62297B1 (sr) 2011-11-23 2021-09-30 Therapeuticsmd Inc Prirodne kombinovane hormonske supstitucione formulacije i terapije
JP2015518854A (ja) 2012-05-23 2015-07-06 セリックスビオ プライヴェート リミテッド 多発性硬化症の治療のための組成物および方法
NZ701832A (en) 2012-05-23 2016-08-26 Cellix Bio Private Ltd Compositions and methods for treatment of inflammatory bowel disease
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
WO2016128991A1 (en) 2015-02-09 2016-08-18 Cellix Bio Private Limited Compositions and methods for the treatment of mucositis
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
EP3174542A4 (de) 2014-07-29 2018-01-03 TherapeuticsMD, Inc. Transdermale creme
SG11201706952VA (en) 2014-09-26 2017-10-30 Cellix Bio Private Ltd Compositions and methods for the treatment of epilepsy and neurological disorders
EP3201168B1 (de) 2014-09-29 2020-03-18 Cellix Bio Private Limited Verbindungen und zusammensetzungen zur behandlung multipler sklerose
WO2016067297A1 (en) 2014-10-27 2016-05-06 Cellix Bio Private Limited Salts of valproic acid with piperazine, ethylenediamine, lysine and/or eicosapentaenoic ecid (epa) amine derivatives for the treatment of epilepsy
AU2014414316B2 (en) 2014-10-27 2020-04-09 Cellix Bio Private Limited Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis
WO2016088132A1 (en) 2014-12-01 2016-06-09 Cellix Bio Private Limited Compositions and methods for the treatment of multiple sclerosis
WO2016112342A1 (en) * 2015-01-09 2016-07-14 Hemcon Medical Technologies, Inc. Percutaneous vascular injury treatment systems and methods
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
MX387330B (es) 2016-08-11 2025-03-18 Cellix Bio Private Ltd Composiciones y metodos para el tratamiento de sindrome de intestino irritable
WO2018065831A1 (en) 2016-10-04 2018-04-12 Cellix Bio Private Limited Compositions and methods for the treatment of xerostomia
EP3554494A4 (de) 2016-12-19 2021-02-17 Cellixbio Private Limited Zusammensetzungen und verfahren zur behandlung von entzündungen
WO2019023605A1 (en) 2017-07-27 2019-01-31 Allergan, Inc. PROSTACYCLINE RECEPTOR AGONISTS FOR BODY GREASE REDUCTION
KR102405239B1 (ko) 2017-11-17 2022-06-08 셀릭스 바이오 프라이빗 리미티드 눈 질환 및 피부 질환의 치료를 위한 화합물, 조성물 및 방법
AU2018367909B2 (en) 2017-11-17 2022-03-10 Cellix Bio Private Limited Compositions and methods for the treatment of eye disorders
EP4007581A4 (de) 2019-08-02 2023-10-25 Enterin, Inc. Dosierungsprotokolle und regimes zur aminosterolbehandlung
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system
CA2065311C (en) * 1989-09-08 2000-01-11 Chia-Ming Chiang Solid matrix system for transdermal drug delivery
US5252334A (en) * 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
US5676968A (en) * 1991-10-31 1997-10-14 Schering Aktiengesellschaft Transdermal therapeutic systems with crystallization inhibitors
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
DE4223360C1 (de) * 1992-07-16 1993-04-08 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
DE4237453C1 (de) * 1992-11-06 1993-08-19 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4333595A1 (de) * 1993-10-01 1995-04-06 Labtec Gmbh Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
JPH0827003A (ja) * 1994-07-22 1996-01-30 Sekisui Chem Co Ltd 経皮吸収製剤
DE4429664C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
DE19548332A1 (de) * 1995-12-22 1997-07-10 Rotta Res Bv Hormonpflaster
DE19600347A1 (de) * 1996-01-08 1997-07-10 Lohmann Therapie Syst Lts Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus

Also Published As

Publication number Publication date
CN1306421A (zh) 2001-08-01
HUP0102785A2 (hu) 2002-01-28
EP1089722A1 (de) 2001-04-11
BR9911411A (pt) 2001-10-23
DE69901561D1 (de) 2002-06-27
JP2002518434A (ja) 2002-06-25
US6440454B1 (en) 2002-08-27
AU4775499A (en) 2000-01-10
ATE217793T1 (de) 2002-06-15
EP1089722B1 (de) 2002-05-22
CA2333586A1 (en) 1999-12-29
WO1999066908A1 (en) 1999-12-29
DK1089722T3 (da) 2002-07-01
PT1089722E (pt) 2002-09-30
KR20010053072A (ko) 2001-06-25
DE69901561T2 (de) 2002-10-10
ES2177295T3 (es) 2002-12-01
PL345061A1 (en) 2001-11-19
DE19827732A1 (de) 1999-12-23

Similar Documents

Publication Publication Date Title
PL345061A1 (en) Matrix-type transdermal patch for steroid hormones
HUP9802326A2 (hu) 17-Dezacetil-norgesztimát vagy valamely ösztrogénnel kombinált hatóanyag bevitelére alkalmas transzdermális készítmény
DE59808922D1 (en) Transdermales therapeutisches system
MXPA04001676A (es) Sistema terapeutico transdermico con fentanilo o sustancias relacionadas.
MY106628A (en) Estrogen-containing active substance plaster
PT748190E (pt) Metodos e formulacoes para uso no tratamento de disturbios ginecologicos benignos
EP0737052A4 (de) Transdermales medikamentenverabreichungssystem
CA2391430A1 (en) Improved transdermal contraceptive delivery system and process
CO5251434A1 (es) Composicion de liberacion controlada
MXPA02003917A (es) Productos de papel tisu que contienen agentes antivirales que son suaves.
HUP0200173A2 (en) Combined use of estrogen and progestogen, norethindrone acetate and ethinyl estradiol for preparing pharmaceutical compositions for preventing and treating skin aging and acne
AU3428200A (en) Device for releasing cosmetic active substances
WO1998036740A3 (de) Transdermales oder topisches pflastersystem mit polyacrylatmatrix mit verbesserten physikalischen eigenschaften
HU900199D0 (en) Process for production of surface therapic system comprising 5-fluoruracil as active ingredient
WO2002017928A3 (de) Transdermales therapeutisches system zur abgabe von exemestan
KR970701538A (ko) 데소게스트렐 함유 경피 투여제(desogestrel-containing transdermal vapplication agent)
AR018475A1 (es) Composicion de resorcinol
AU3221495A (en) Transdermal delivery device containing an estrogen
BRPI0011135B8 (pt) sistema de ministração terapêutica transdérmica contendo agente neuroléptico
GB9809082D0 (en) Delivery device
CA2414753A1 (en) Dermal therapeutic system containing 2-(3-benzophenyl)-propionic acid or [0-(2,6-dichloranilino)-phenyl]-ethanoic acid
IL114948A0 (en) A transdermal therapeutic system containing estradiol and a process for the preparation thereof
IL134479A0 (en) Process for producing a transdermal therapeutic system with protection against oral use
AU9627898A (en) Tightening and/or reducing the size of body parts containing fat cells
JP2005255649A (ja) 貼付シート